13-cis-retinoic acid is a Vitamin A analog currently used for maintenance therapy in treatment regimens for children with high-risk neuroblastoma [3], and 13-cis-retinoic acid has been shown to induce neuroblastoma tumor differentiation, decrease MYCN expression, and decrease neuroblastoma cell proliferation [27–30]. This evidence concerns the gene MYCN and neoplasm.